Merck & Co., Inc. (MRK) Insider Trading & Ownership $97.43 +0.89 (+0.92%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Merck & Co., Inc. (NYSE:MRK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.09%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$6.55 M Get MRK Insider Trade Alerts Want to know when executives and insiders are buying or selling Merck & Co., Inc. stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRK Insider Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Merck & Co., Inc. Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/24/2024Jonathan L. JacksonU.S. Congress Member (D-IL)Sell$114.96$15,001 - $50,0009/4/2024John JamesU.S. Congress Member (R-MI)Sell$115.80$1,001 - $15,0008/2/2024C. Scott FranklinU.S. Congress Member (R-FL)Buy$115.20$1,001 - $15,0007/2/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$127.72$1,001 - $15,0006/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$130.56$1,001 - $15,0004/10/2024Michael C. BurgessU.S. Congress Member (R-TX)Sell$126.73$1,001 - $15,0002/13/2024Joseph RomanelliInsiderSell1,000$124.89$124,890.00 2/2/2024Steven MizellEVPSell50,694$126.65$6,420,395.10 (Data available from 1/1/2013 forward) MRK Insider Trading Activity - Frequently Asked Questions Who is on Merck & Co., Inc.'s Insider Roster? The list of insiders at Merck & Co., Inc. includes Johannes Jacobus Oosthuizen, Joseph Romanelli, Kenneth C Frazier, Richard R Deluca, Rita A Karachun, Robert M Davis, Sanat Chattopadhyay, and Steven Mizell. Learn more on insiders at MRK. What percentage of Merck & Co., Inc. stock is owned by insiders? 0.09% of Merck & Co., Inc. stock is owned by insiders. Learn more on MRK's insider holdings. Which Merck & Co., Inc. insiders have been buying company stock? The following insider purchased MRK shares in the last 24 months: Joseph Romanelli ($15,886.16). How much insider buying is happening at Merck & Co., Inc.? Insiders have purchased a total of 150 MRK shares in the last 24 months for a total of $15,886.16 bought. Which Merck & Co., Inc. insiders have been selling company stock? The following insiders have sold MRK shares in the last 24 months: Johannes Jacobus Oosthuizen ($213,052.78), Joseph Romanelli ($669,652.75), Richard R Deluca ($20,964,313.77), Rita A Karachun ($1,865,788.75), Robert M Davis ($16,472,801.97), Sanat Chattopadhyay ($24,857,395.11), and Steven Mizell ($14,908,996.10). How much insider selling is happening at Merck & Co., Inc.? Insiders have sold a total of 694,886 Merck & Co., Inc. shares in the last 24 months for a total of $79,952,001.23 sold. Which members of congress are trading Merck & Co., Inc.? C. Scott Franklin (R-FL), Kathy E. Manning (D-NC), and Jared Moskowitz (D-FL) have bought shares of Merck & Co., Inc. in the last year totaling $64,500. Jonathan L. Jackson (D-IL), John James (R-MI), Josh Gottheimer (D-NJ), and Michael C. Burgess (R-TX) have sold shares totaling $56,500. Merck & Co., Inc. Key ExecutivesMr. Robert M. Davis J.D. (Age 57)Chairman, President & CEO Compensation: $5.57MMs. Caroline Litchfield (Age 55)Executive VP & CFO Compensation: $3.09MMr. Richard R. DeLuca Jr. (Age 61)Executive VP & President of Merck Animal Health Compensation: $2.4MMr. Sanat Chattopadhyay (Age 64)Executive VP & President of Merck Manufacturing Division Compensation: $2.49MDr. Dean Y. Li M.D. (Age 61)Ph.D., Executive VP & President of Merck Research Laboratories Compensation: $3.61MMr. Dalton E. Smart III (Age 57)Senior VP of Finance, Principal Accounting Officer & Global Controller Mr. David Michael Williams (Age 55)Executive VP and Chief Information & Digital Officer Mr. Peter DannenbaumVice President of Investor RelationsMs. Jennifer L. Zachary (Age 46)Executive VP & General Counsel Compensation: $2.73MLisa LeCointe-Cephas (Age 42)Senior VP and Chief Ethics & Compliance Officer More Insider Trading Tools from MarketBeat Related Companies Eli Lilly and Company Insider Selling Johnson & Johnson Insider Selling AbbVie Insider Selling Pfizer Insider Selling Bristol-Myers Squibb Insider Selling Zoetis Insider Selling Royalty Pharma Insider Selling Jazz Pharmaceuticals Insider Selling Corcept Therapeutics Insider Selling Perrigo Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NYSE:MRK) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck & Co., Inc. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
